Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia

Half of the patients with acute myeloid leukemia (AML), who achieve complete remission after chemotherapy treatment, will ultimately experience a relapse. Measurable residual disease (MRD) is an important post‐treatment risk factor in AML, because it gives additional information about the depth of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeijlemaker, Wendelien, Kelder, Angele, Cloos, Jacqueline, Schuurhuis, Gerrit Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856793/
https://www.ncbi.nlm.nih.gov/pubmed/31763792
http://dx.doi.org/10.1002/cpcy.66

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856793/
https://www.ncbi.nlm.nih.gov/pubmed/31763792
http://dx.doi.org/10.1002/cpcy.66

Ejemplares similares